title: Effect of biphasic waveform pulse on endocardial defibrillation efficacy in humans.
abstract: Several clinical studies have proved increased defibrillation efficacy for implantable cardioverter defibrillators with biphasic pulse waveforms compared to monophasic pulse waveforms. This difference in defibrillation efficacy depends on the type of defibrillation lead system used. The influence of biphasic defibrillation pulse waveforms on the defibrillation efficacy of purely endocardial defibrillation lead systems has not yet been sufficiently examined, we, therefore studied 30 consecutive patients with drug refractory ventricular tachyarrhythmias during the implantation of a cardioverter defibrillator. After implanting an endocardial "integrated" sensing/defibrillation lead we performed a prospective randomized comparison of the defibrillation efficacy of monophasic and biphasic defibrillation waveform pulses. For endocardial defibrillation with the biphasic waveform the mean defibrillation threshold was 12.5 +/- 4.9 joules and for the monophasic waveform 22.2 +/- 5.6 joules (P < 0.0001). There was a decrease in the required defibrillation energy of biphasic defibrillation in 29/30 patients. Thus considering purely endocardial defibrillation a statistically significant and clinically relevant increase in defibrillation efficacy can be demonstrated for biphasic defibrillation waveform pulses.
authors.affiliation: Kerckhoff-Clinic, Max Planck Society, Bad Nauheim, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Neuzner
authors.forename: H F
authors.initials: HF
authors.lastname: Pitschner
authors.forename: C
authors.initials: C
authors.lastname: Huth
authors.forename: M
authors.initials: M
authors.lastname: Schlepper
mesh_terms: D017147:Defibrillators, Implantable; D004526:Efficiency; D004553:Electric Conductivity; D004554:Electric Countershock / Q000379:methods*; D017097:Electric Impedance; D004567:Electrodes, Implanted; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D017180:Tachycardia, Ventricular / Q000628:therapy; D014693:Ventricular Fibrillation / Q000628:therapy